Blood Fatty Acids Profile in MIS-C Children.
arachidonic acid
docosahexaenoic acid
eicosanoids
inflammation
specialized pro-resolution mediators
Journal
Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790
Informations de publication
Date de publication:
22 Oct 2021
22 Oct 2021
Historique:
received:
07
10
2021
revised:
15
10
2021
accepted:
18
10
2021
entrez:
25
11
2021
pubmed:
26
11
2021
medline:
26
11
2021
Statut:
epublish
Résumé
MIS-C (multisystem inflammatory syndrome in children) linked to SARS-CoV-2 infection, is a pathological state observed in subjects younger than 21 years old with evidence of either current SARS-CoV-2 infection or exposure within the 4 weeks prior to the onset of symptoms, the presence of documented fever, elevated markers of inflammation, at least two signs of multisystem involvement, and, finally, lack of an alternative diagnosis. They share with adult COVID-19 patients the presence of altered markers of inflammation, but unlike most adults the symptoms are not pulmonary but are affecting several organs. Lipid mediators arising from polyunsaturated fatty acids (PUFA) play an important role in the inflammatory response, with arachidonic acid-derived compounds, such as prostaglandins and leukotrienes, mainly pro-inflammatory and ω3 PUFA metabolites such as resolvins and protectins, showing anti-inflammatory and pro-resolution activities. In order to assess potential alterations of these FA, we evaluated the blood fatty acid profile of MIS-C children at admission to the hospital, together with biochemical, metabolic and clinical assessment. All the patients enrolled showed altered inflammatory parameters with fibrinogen, D-dimer, NT-proBNP, ferritin, aspartate aminotransferase (AST), C-reactive protein (CRP) and TrygIndex levels over the reference values in all the subjects under observation, while albumin and HDL-cholesterol resulted below the normal range. Interestingly, linoleic acid (LA), arachidonic acid (AA) and the ω3 PUFA docosahexaenoic acid (DHA) results were lower in our study when compared to relative amounts reported in the other studies, including from our own laboratory. This significant alteration is pointing out to a potential depletion of these PUFA as a result of the systemic inflammatory condition typical of these patients, suggesting that LA- and AA-derived metabolites may play a critical role in this pathological state, while ω3 PUFA-derived pro-resolution metabolites in these subjects may not be able to provide a timely, physiological counterbalance to the formation of pro-inflammatory lipid mediators. In conclusion, this observational study provides evidence of FA alterations in MIS-C children, suggesting a significant contribution of ω6 FA to the observed inflammatory state, and supporting a potential dietary intervention to restore an appropriate balance among the FAs capable of promoting the resolution of the observed inflammatory condition.
Identifiants
pubmed: 34822379
pii: metabo11110721
doi: 10.3390/metabo11110721
pmc: PMC8624489
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Atherosclerosis. 2015 Jun;240(2):431-6
pubmed: 25897795
Int J Vitam Nutr Res. 1998;68(3):159-73
pubmed: 9637947
Int J Pediatr Obes. 2011 Jun;6(2-2):e532-9
pubmed: 21226540
Diabetes Care. 2015 Jan;38 Suppl:S8-S16
pubmed: 25537714
J Am Coll Emerg Physicians Open. 2021 Jan 29;2(1):e12375
pubmed: 33554209
Crit Care. 2020 Jun 11;24(1):327
pubmed: 32527297
J Clin Res Pediatr Endocrinol. 2019 May 15;:
pubmed: 31088046
Prostaglandins Leukot Essent Fatty Acids. 2016 Jan;104:1-10
pubmed: 26802936
J Clin Invest. 2018 Jul 2;128(7):2657-2669
pubmed: 29757195
Eur J Pediatr. 2021 Jul;180(7):2019-2034
pubmed: 33599835
Pharmacol Ther. 2021 Mar;219:107703
pubmed: 33031856
Prostaglandins Leukot Essent Fatty Acids. 2007 Jun;76(6):363-9
pubmed: 17588731
Pharmacol Res. 2020 Sep;159:104951
pubmed: 32464327
Front Cell Dev Biol. 2021 Jun 14;9:675310
pubmed: 34195193
Saudi Med J. 2021 Mar;42(3):299-305
pubmed: 33632909
Int J Mol Sci. 2020 May 30;21(11):
pubmed: 32486144
Nutrition. 2021 Jan;81:110900
pubmed: 32738510
Adv Nutr. 2013 May 01;4(3):311-2
pubmed: 23674797
JAMA. 2020 Jun 16;323(23):2427-2429
pubmed: 32432657
Prostaglandins Leukot Essent Fatty Acids. 2021 Mar;166:102250
pubmed: 33516093
Metab Syndr Relat Disord. 2008 Dec;6(4):299-304
pubmed: 19067533
J Nutr Biochem. 2020 Dec;86:108484
pubmed: 32827665
J Transl Med. 2021 Mar 29;19(1):128
pubmed: 33781275
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Mol Aspects Med. 2020 Aug;74:100894
pubmed: 32893032
Children (Basel). 2021 May 13;8(5):
pubmed: 34067965
Prostaglandins. 1991 Jul;42(1):1-7
pubmed: 1771235
Prostaglandins Leukot Essent Fatty Acids. 2013 Sep;89(4):215-20
pubmed: 23910046
Trends Mol Med. 2019 Mar;25(3):198-214
pubmed: 30795972
Pediatrics. 2011 Dec;128 Suppl 5:S213-56
pubmed: 22084329
Lancet. 2020 May 23;395(10237):1607-1608
pubmed: 32386565
Rev Bras Enferm. 2021 Jan 29;74Suppl 1(Suppl 1):e20200624
pubmed: 33533805
BMJ Evid Based Med. 2021 Jun;26(3):107-108
pubmed: 32934000
Front Physiol. 2021 Apr 01;12:663869
pubmed: 33868029
J Thromb Haemost. 2020 Sep;18(9):2103-2109
pubmed: 32558075
Vaccine. 2021 May 21;39(22):3037-3049
pubmed: 33640145
J Atheroscler Thromb. 2011;18(4):345-50
pubmed: 21307609
Eur J Clin Nutr. 2016 Jul;70(7):819-23
pubmed: 26757836
Pediatr Infect Dis J. 2020 Aug;39(8):e195-e198
pubmed: 32467457
Front Pharmacol. 2020 Aug 06;11:1214
pubmed: 32848802
Med Hypotheses. 2020 Dec;145:110340
pubmed: 33069094
Front Public Health. 2021 Jan 20;8:587374
pubmed: 33553089
Clin Pediatr (Phila). 2008 May;47(4):355-62
pubmed: 18180340
Lancet. 2020 Jun 6;395(10239):1771-1778
pubmed: 32410760
Int J Obes (Lond). 2014 Sep;38 Suppl 2:S86-98
pubmed: 25219413
Ital J Pediatr. 2021 Feb 8;47(1):24
pubmed: 33557873
Front Immunol. 2020 Aug 11;11:1997
pubmed: 32983141
Can J Physiol Pharmacol. 2014 Oct;92(10):839-47
pubmed: 25243774
J Lipid Res. 2015 Sep;56(9):1808-20
pubmed: 26180051
J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):393-398
pubmed: 32463092
Lifestyle Genom. 2021;14(2):37-42
pubmed: 33530084
J Atten Disord. 2018 Aug;22(10):971-983
pubmed: 26861157
Essays Biochem. 2020 Sep 23;64(3):423-441
pubmed: 32808658
Am J Respir Cell Mol Biol. 2001 Oct;25(4):434-8
pubmed: 11694448
Anal Biochem. 2004 Mar 15;326(2):267-72
pubmed: 15003567
Cell. 2020 Jul 9;182(1):59-72.e15
pubmed: 32492406
Circulation. 2020 Aug 4;142(5):429-436
pubmed: 32418446
J Pediatr (Rio J). 2019 Mar - Apr;95(2):217-223
pubmed: 29457996
Nutrients. 2019 May 30;11(6):
pubmed: 31151199
Biochemistry (Mosc). 1998 Jan;63(1):84-92
pubmed: 9526099
Children (Basel). 2020 Jul 01;7(7):
pubmed: 32630212
J Med Chem. 2019 Nov 14;62(21):9961-9975
pubmed: 31626541
Cell Metab. 2020 Aug 4;32(2):188-202.e5
pubmed: 32610096
Annu Rev Pathol. 2008;3:279-312
pubmed: 18233953
Atherosclerosis. 2020 Jan;292:90-98
pubmed: 31785494
Prev Med. 2016 May;86:99-105
pubmed: 26854766
Front Physiol. 2021 Apr 30;12:659551
pubmed: 33995124